tradingkey.logo

Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors

ReutersApr 29, 2025 5:39 PM

- Gilead Sciences GILD.O has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S. attorney's office in Manhattan said on Tuesday.

The settlement resolves claims that Gilead paid honoraria, meals and travel expenses to doctors who attended Gilead speaker events to induce them to prescribe several HIV drugs.

U.S. Attorney Jay Clayton said this violated the federal False Claims Act by causing claims to be paid by federal healthcare programs.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI